Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Study of the effect of marketed Chinese patent medicine on inhibiting release of inflammatory factors in macrophage models
Hits 1028  Download times 750  Received:March 28, 2020  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2020.10.07
Key Words   Chinese patent medicine;RAW264.7 cell;LPS;cytokine inflammation
Author NameAffiliationE-mail
GUO Hong Research Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
PU Weiling Research Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
ZHOU Kun Research Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
HAN Lifeng Research Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
HAO Jia Research Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
CHANG Yanxu Research Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
GAO Xiumei Research Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
WANG Tao Research Institute of Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China wangtao@tjutcm.edu.cn。 
Abstract
    [Objective] The "cytokine storm" caused by immune system hyper-activation after viral infection is an important reason for the conversion of viral pneumonia from mild to severe,and also the important reason for complications in severe patients. In this paper,we screen marketed Chinese patent medicines with significant inhibition in cytokines secretion are provide scientific basis for the treatment of viral pneumonia.[Methods] We investigated the inhibition of inflammatory factors of marketed medicines in lipopolysaccharide (LPS)-induced RAW264.7 cells model. To detect the production of nitric oxide (NO) by Griess method,detect secretion of cytokines TNF-α,IL-1β,IL-2,IL-6,IL-10 by the enzymatic immunoassay kits.[Results] The results here report that Niuhuang Qingxin pill,Huoxiang Zhengqi soft capsule,Niuhuang Jiedu pill,and Andrographolide dropping pill can inhibit NO production and cytokine secretion in LPS induced RAW264.7 cells,suggesting that these marketed Chinese patent medicine have the activity of inhibiting inflammatory factors.[Conclusion] Niuhuang Qingxin pill,Huoxiang Zhengqi soft capsule,Niuhuang Jiedu pill,and Andrographolide dropping pill have the effect of inhibiting "cytokine storm",and have more promising clinical applications.

You are the 2312535 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.